Partial deletion of chromosome 16 syndrome

Partial deletion of chromosome 16 syndrome (Orphanet code 261826) refers to a group of rare chromosomal anomalies characterized by the loss of a segment of chromosome 16. Because chromosome 16 contains numerous genes involved in diverse developmental and physiological processes, partial deletions can affect multiple body systems depending on the size and precise location of the deleted segment. Clinical features are highly variable but may include intellectual disability, developmental delay, growth retardation, craniofacial dysmorphism, congenital heart defects, and various organ malformations. Some patients may also present with behavioral difficulties, seizures, and skeletal anomalies. The phenotypic spectrum is broad because different regions of chromosome 16 (short arm or long arm) can be involved, and the extent of the deletion varies from patient to patient. Well-characterized subtypes include deletions of 16p13.3 (associated with Rubinstein-Taybi syndrome or alpha-thalassemia intellectual disability syndrome), 16p11.2 (associated with autism spectrum disorder and obesity), and various long-arm deletions, each with distinct clinical profiles. This Orphanet entry serves as an umbrella category for partial chromosome 16 deletions that do not fall neatly into a more specific recognized syndrome. There is no curative treatment for partial deletion of chromosome 16 syndrome. Management is supportive and symptom-based, typically involving a multidisciplinary team including pediatricians, neurologists, cardiologists, speech and occupational therapists, and clinical geneticists. Early intervention programs for developmental delay and individualized educational support are important components of care. Genetic counseling is recommended for affected families to assess recurrence risk and to guide family planning decisions.

Common questions about Partial deletion of chromosome 16 syndrome